Indefinite Delivery Contract SPE2D023D0004
Award Date 9/1/23
Last Date to Order 5/31/25
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- The federal contract IDV is a Multiple Award Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Xellia Pharmaceuticals USA LLC, a pharmaceutical manufacturing company. The contract, valued up to $250,000, is for the provision of drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 IB. Xellia Pharmaceuticals USA LLC, a division of the global specialty pharmaceutical company Xellia Pharmaceuticals, primarily supplies critical...
- The Department of Defense Medical Supply Chain awarded a single-award IDIQ to X-Gen Pharmaceuticals, Inc. with a ceiling of $7,535,563.45 on June 26, 2019, with ultimate completion on June 25, 2029. X-Gen Pharmaceuticals, Inc. is a woman-owned small business. Work is performed in Horseheads, New York. The IDIQ procures injectable pharmaceutical products and medical supplies including rocuronium, amphotericin B, acetazolamide, promethazine solutions, and ammonia aromatic solution to support...
- The Defense Logistics Agency's Medical Supply Chain awarded a single-award IDIQ to Hikma Pharmaceuticals USA Inc. with a ceiling of $42,907,335.98 on July 14, 2020, for manufacture and distribution of pharmaceutical products. The contract extends through July 14, 2030. Work is performed at Hikma's facility in Berkeley Heights, New Jersey. This vehicle procures generic injectable and non-injectable pharmaceutical products including vancomycin, doxycycline hyclate, ephedrine sulfate, naloxone,...
- The Medical Supply Chain (Defense) awarded a single-award IDIQ to Exelan Pharmaceuticals Inc. with a ceiling of $6,984,109.81 on February 12, 2024, for pharmaceutical manufacturing and distribution services, with ultimate completion on February 11, 2029. The contract carries no set-aside designation. Place of performance is Boca Raton, Florida and designated delivery locations for the contracting federal agencies. The IDIQ originated from a pre-solicitation posted February 15, 2023, and procures...
- The Defense Logistics Agency Medical Supply Chain awarded a single-award indefinite delivery contract to Sagent Pharmaceuticals, Inc. on March 4, 2021, with a ceiling of $29.6 million and an ultimate completion date of March 3, 2031. The contract procures injectable pharmaceutical products including antibiotics (levofloxacin, ciprofloxacin, cefepime, ampicillin-sulbactam, metronidazole), anesthetics (propofol), and critical care medications (adenosine). Performance occurs at Sagent...
- This is a single-award Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at up to $4,999,999, is focused on delivering a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The contract covers an...
- The Defense Logistics Agency (operating under the Defense or Civilian designation "Defense" within the Medical Supply Chain) awarded a single-award indefinite-delivery contract to Alvogen, Inc. with a ceiling of $6,017,237.19 on September 11, 2017, with an ultimate completion date of September 10, 2027. Place of performance is Morristown, New Jersey. The IDIQ procures pharmaceutical and medical supplies, including generic pharmaceuticals, for military medical supply chain operations....
- The Defense Logistics Agency awarded an indefinite delivery contract to DMS Pharmaceutical Group Inc. to provide pharmaceutical products and medical supplies in support of DOD programs. The IDIQ has a potential value of $499,999,999 and period of performance through December 2025. Under the contract, DMS Pharmaceutical Group will deliver a variety of prescription drugs, medical devices, and other supplies from its facility in Park Ridge, Illinois on a series of fixed price delivery orders....
- The Defense Logistics Agency Medical Supply Chain awarded an indefinite-delivery contract to Fresenius Kabi, LLC on July 30, 2020, with a ceiling value of $39.2 million. This is a single-award contract with no set-aside designation and ultimate completion on July 29, 2030. Place of performance is Lake Zurich, Illinois. The contract procures injectable pharmaceutical products and biologics, including ketorolac, diphenhydramine, xylocaine (lidocaine), furosemide, rocuronium, protamine, atropine,...
- The Defense Logistics Agency awarded an indefinite-delivery/indefinite-quantity contract to DMS Pharmaceutical Group Inc. to provide pharmaceutical products in support of Department of Defense programs. The contract has a potential value of $499,999,999 and a period of performance through December 2025. Task orders issued by the Defense Logistics Agency against this contract include delivery of various prescription medications to locations in Park Ridge, Illinois, including cystic fibrosis drugs...
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order SPE2D023D0004-SPE2D323F218B | Xellia Pharmaceuticals USA LLC | $30.8k | 9/14/23 | 9/19/23 | 9/14/23 | |
Delivery Order SPE2D023D0004-SPE2D323F218P | Xellia Pharmaceuticals USA LLC | $58.9k | 9/14/23 | 9/19/23 | 9/14/23 | |
Delivery Order SPE2D023D0004-SPE2D323F217U | Xellia Pharmaceuticals USA LLC | $124.1k | 9/14/23 | 9/19/23 | 9/14/23 | |
Delivery Order SPE2D023D0004-SPE2D324F6600 | Xellia Pharmaceuticals USA LLC | $43 | 2/29/24 | 3/5/24 | 2/29/24 | |
Delivery Order SPE2D023D0004-SPE2D323F217Z | Xellia Pharmaceuticals USA LLC | $39.1k | 9/14/23 | 9/19/23 | 9/14/23 |